Stock market week-in-review for 5 large GI companies — Dec. 11-15

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Dec. 11 to Dec. 15, 2017.

Advertisement

Note: This data was compiled using Yahoo Finance.

1. Allergan Pharmaceuticals

Opened: $168.75 on Dec. 11
Peaked: $175.20 on Dec. 14
Closed: $171.68 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 1.73 percent

2. Exact Sciences Corp.

Opened: $53.58 on Dec. 11
Peaked: $53.96 on Dec. 11
Closed: $51.56 on Dec. 15
Percent change between Dec. 11 and Dec. 15: -3.77 percent

3. Johnson & Johnson

Opened: $140.90 on Dec. 11
Peaked: $143.57 on Dec. 12
Closed: $142.46 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 1.1 percent

4. Synergy Pharmaceuticals

Opened: $1.93 on Dec. 11
Peaked: $2.10 on Dec. 15
Closed: $2.01 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 4.14 percent

5. Valeant Pharmaceuticals

Opened: $19.80 on Dec. 11
Peaked: $22.81 on Dec. 13
Closed: $19.71 on Dec. 15
Percent change between Dec. 11 and Dec. 15: -0.45 percent

More articles on gastroenterology: 
GI leader to know: Dr. Anil Sharma of Gastroenterology Group of Rochester
82% of early-onset CRC cases misdiagnosed — 10 study insights
Takeda, TiGenix’s complex perianal fistulas treatment receives 1st ever positive EMA opinion — 3 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.